🇺🇸 TPO-RAs combining anti-CD 20 monoclonal antibody in United States

TPO-RAs combining anti-CD 20 monoclonal antibody (TPO-RAs combining anti-CD 20 monoclonal antibody) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

TPO-RAs combining anti-CD 20 monoclonal antibody in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is TPO-RAs combining anti-CD 20 monoclonal antibody approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for TPO-RAs combining anti-CD 20 monoclonal antibody in United States?

Institute of Hematology & Blood Diseases Hospital, China is the originator. The local marketing authorisation holder may differ — check the official source linked above.